4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-043323
Options or other derivatives
- Director acquired 119,178 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Huang James Director | 2020-07-20 | Grant or award · Stock Option (right to buy) | +119,178 | 119,178 | D | ||
Loading xslF345X03/doc4.xml…